Study S000276

An Exploratory Study Assessing the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06361823
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 74
Start: 2024-05-01
Primary completion: 2024-12-01
Lead sponsor: Capital Medical University
Conditions: Idiopathic Intracranial Hypertension
Interventions: DRUG:Semaglutide; DIETARY_SUPPLEMENT:Low calorie diet
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Intracranial pressure [12 weeks]
Adverse reactions [12 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0003243	Effect of Semaglutide on Recurrence of Intracranial Hypertension After Venous Sinus Stenting: A Two-Phase Cohort Study Lu C, Research Square	2026	Randomized trial	DOI	cites ClinicalTrials.gov:NCT06361823